Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01209637
Other study ID # SMW 04
Secondary ID
Status Completed
Phase N/A
First received September 24, 2010
Last updated October 25, 2016
Start date March 2010
Est. completion date December 2012

Study information

Verified date October 2016
Source University of Leipzig
Contact n/a
Is FDA regulated No
Health authority Germany: Ethics Commission
Study type Interventional

Clinical Trial Summary

Exercise training in patients with coronary artery disease is able to correct several risk factors. Furthermore endothelial function can be improved.

There are some hinds for improved collateral circulation after exercise training, nevertheless there is no study showing significant improvement/ increase in coronary collaterals. This might be due to technique of collateral measurement. Therefore we conduct a study were coronary blod flow before and after 4 weeks of exercise training were measured.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date December 2012
Est. primary completion date December 2012
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- stable CAD

- min.1 coronary artery stenosis >50%

- patient is symptomatic ( CCS 1-3)or has documented myocardial ischemia during stress test

- angina threshold >75 Watt

- informed consent

Exclusion Criteria:

- Age <18 oder >75

- akut coronary syndrome within 2 weeks

- LV-EF < 40 %

- significant valve diseases

- reduced patient compliance

- muscular disorder

- bronchial asthma or COLD stadium III and IV

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Intervention

Behavioral:
exercise training
exercise training min. 4 times a day for at least 30 min
Intensive exercise training
Intensive exercise training for 4 times / day incl. interval training at 95% individual threshold

Locations

Country Name City State
Germany Heart Center Leipzig- University Leipzig Leipzig

Sponsors (1)

Lead Sponsor Collaborator
University of Leipzig

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary coronary collateral blod flow 4 weeks No
Secondary plaque composition within the coronary artery plaque composition measured by virtual histology intravascular ultrasound 4 weeks No
Secondary MACCE major cardiovascular events (death, myocardial infarction, stroke, TIA, coronary revascularisation, hospitalisation) 4 week, 6 months, 12 months Yes
Secondary atherosclerosis parameter within the laboratory e.g. wie hs-CRP, HDL, LDL, ges. Cholesterin, Triglyceride, Zytokine, Adipokine, Endocannaboide 4 weeks, 3, 6, 12 months No
See also
  Status Clinical Trial Phase
Completed NCT01205425 - Computed Tomography Coronary Angiography Before Stent Implantation N/A
Completed NCT01243099 - Prospective Study to Assess DES Re-endothelization in BMS Restenosis and De-novo Lesions N/A
Completed NCT03312855 - Intracoronary Stenting and Antithrombotic Regimen: Lesion Platelet Adhesion as Selective Target of Endovenous Revacept Phase 2
Completed NCT00642811 - A Study of the Antiplatelet Effects Comparing Ticagrelor (Ticag. - AZD6140) With Clopidogrel (Clop.) Responder and Non-responders Phase 2
Recruiting NCT03089450 - To Evaluate Safety and Efficacy of CGBIO Stent Compared to Biomatrix Flex Stent N/A
Completed NCT01523392 - A Pharmacodynamic Study With Ticagrelor in African American Patients Phase 4
Active, not recruiting NCT04434365 - Effect of Berberine for Endothelial Function and Intestinal Microflora in Patients With Coronary Artery Disease Phase 1/Phase 2
Completed NCT00510588 - Chronic Inflammatory Activation in Fat Tissue: an Atherogenic Factor in Stable Coronary Artery Disease N/A
Completed NCT03384966 - A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery Disease Phase 2
Active, not recruiting NCT01609465 - Prognostic Models for People With Stable Coronary Artery Disease N/A
Terminated NCT00911339 - Mobilization of Endothelial Progenitor Cells Induced by Atorvastatin in Patients With Stable Coronary Artery Disease Treated With Anti-CD 34 Antibodies Coated Stents Phase 3
Completed NCT00984802 - Safety and Efficacy of CMX-2043 in Subjects Undergoing Coronary Reperfusion Therapy Phase 2
Completed NCT03782688 - Precise Percutaneous Coronary Intervention Plan (P3) Study
Completed NCT02580851 - Magnetic Resonance Adenosine Perfusion Imaging as Gatekeeper of Invasive Coronary Intervention N/A
Recruiting NCT03313752 - Effects of SGLT2 Inhibition on Myocardial Insulin Sensitivity Phase 3
Completed NCT01184300 - ReAssessment of Anti-Platelet Therapy Using an InDividualized Strategy Based on GENetic Evaluation Phase 2/Phase 3
Completed NCT01523366 - A Pharmacodynamic Study With Ticagrelor in Hispanic Patients Phase 4
Completed NCT01118325 - An Asian Study to Assess the Properties and Profile of Ticagrelor in Patients With Stable Coronary Artery Disease Phase 2
Recruiting NCT06123728 - MCG is Clinically Applied to Evaluate Myocardial Ischemic Function in Patients With Stable Coronary Artery Disease